The committee concluded that “It is relevant to authorise using cannabis for therapeutic purposes for clients in certain clinical conditions and in case of insufficient relief or weak tolerance of therapeutics … This use may be regarded as Together with or being a substitute for selected therapies.” contacted him https://emilea604inp0.prublogger.com/profile